Modeling myocardial growth and hypertrophy in engineered heart muscle

Trends in Cardiovascular Medicine

Volumn 24, Issue 1, 2014, Pages 7-13

  Tiburcy, Malte ^a,b   Zimmermann, Wolfram Hubertus ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

BIOMEDICAL ENGINEERING; BIOMIMETICS; BIOTECHNOLOGY; DEVELOPMENTAL STAGE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYDROGEL; MYOCARDIAL DISEASE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SIMULATION; TISSUE ENGINEERING;

ANIMALS; BIOMIMETICS; CARDIOMEGALY; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SHAPE; COLLAGEN; HUMANS; HYDROGELS; MYOCARDIUM; MYOCYTES, CARDIAC; TISSUE ENGINEERING;

EID: 84890787049     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.05.003     Document Type: Review

References (55)

1. Baar K., Birla R., Boluyt M.O., Borschel G.H., Arruda E.M., Dennis R.G. Self-organization of rat cardiac cells into contractile 3-D cardiac tissue. FASEB Journal 2005, 19:275-277.
2. Banerjee I., Fuseler J.W., Price R.L., Borg T.K., Baudino T.A. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. American Journal of Physiology-Heart and Circulatory Physiology 2007, 293:H1883-H1891.
3. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
4. Burridge P.W., Keller G., Gold J.D., Wu J.C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012, 10:16-28.
5. Bursac N., Papadaki M., Cohen R.J., et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. American Journal of Physiology 1999, 277:H433-H444.
6. Carrier R.L., Papadaki M., Rupnick M., et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnology and Bioengineering 1999, 64:580-589.
7. Caspi O., Lesman A., Basevitch Y., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circulation Research 2007, 100:263-272.
8. Chiu L.L., Iyer R.K., King J.P., Radisic M. Biphasic electrical field stimulation aids in tissue engineering of multicell-type cardiac organoids. Tissue Engineering Part A 2011, 17:1465-1477.
9. de Lange W.J., Hegge L.F., Grimes A.C., et al. Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease. Circulation Research 2011, 109:8-19.
10. Desroches B.R., Zhang P., Choi B.R., et al. Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells. American Journal of Physiology-Heart and Circulatory Physiology 2012, 302:H2031-H2042.
11. Eschenhagen T., Fink C., Remmers U., et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB Journal 1997, 11:683-694.
12. Hansen A., Eder A., Bonstrup M., et al. Development of a drug screening platform based on engineered heart tissue. Circulation Research 2010, 107:35-44.
13. Holubarsch C., Ruf T., Goldstein D.J., et al. Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. Circulation 1996, 94:683-689.
14. Kamakura T., Makiyama T., Sasaki K., et al. Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circulation Journal 2013, 77:1307-1314.
15. Kehat I., Davis J., Tiburcy M., et al. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circulation Research 2011, 108:176-183.
16. Kehat I., Molkentin J.D. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 2010, 122:2727-2735.
17. Kelm J.M., Djonov V., Hoerstrup S.P., et al. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Engineering 2006, 12:2541-2553.
18. Kensah G., Roa Lara A., Dahlmann J., et al. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. European Heart Journal 2013, 34:1134-1146.
19. Leor J., Aboulafia-Etzion S., Dar A., et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?. Circulation 2000, 102:III56-III61.
20. Leung B.M., Sefton M.V. A modular approach to cardiac tissue engineering. Tissue Engineering Part A 2010, 16:3207-3218.
21. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Choi A., Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation 1999, 100:II63-II69.
22. Lundy S.D., Zhu W.Z., Regnier M., Laflamme M.A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells and Development 2013, Apr 5. [Epub ahead of print] PMID: 23461462.
23. McGuigan A.P., Leung B., Sefton M.V. Fabrication of cell-containing gel modules to assemble modular tissue-engineered constructs [corrected]. Nature Protocols 2006, 1:2963-2969.
24. McNally E.M., Golbus J.R., Puckelwartz M.J. Genetic mutations and mechanisms in dilated cardiomyopathy. Journal of Clinical Investigation 2013, 123:19-26.
25. Mummery C.L., Zhang J., Ng E.S., Elliott D.A., Elefanty A.G., Kamp T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circulation Research 2012, 111:344-358.
26. Munzel F., Muhlhauser U., Zimmermann W.H., et al. Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition. Cardiovascular Research 2005, 68:464-474.
27. Naito H., Melnychenko I., Didie M., et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006, 114:I72-I78.
28. Ott H.C., Matthiesen T.S., Goh S.K., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nature Medicine 2008, 14:213-221.
29. Radisic M., Malda J., Epping E., Geng W., Langer R., Vunjak-Novakovic G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnology and Bioengineering 2006, 93:332-343.
30. Radisic M., Park H., Martens T.P., et al. Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. Journal of Biomedical Materials Research A 2008, 86:713-724.
31. Radisic M., Park H., Shing H., et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:18129-18134.
32. Radisic M., Yang L., Boublik J., et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. American Journal of Physiology-Heart and Circulatory Physiology 2004, 286:H507-H516.
33. Schaaf S., Shibamiya A., Mewe M., et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 2011, 6:e26397.
34. Sekine H., Shimizu T., Sakaguchi K., et al. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nature Communications 2013, 4:1399.
35. Shimizu T., Yamato M., Isoi Y., et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circulation Research 2002, 90:e40.
36. Shinozawa T., Imahashi K., Sawada H., Furukawa H., Takami K. Determination of appropriate stage of human-induced pluripotent stem cell-derived cardiomyocytes for drug screening and pharmacological evaluation in vitro. Journal of Biomolecular Screening 2012, 17:1192-1203.
37. Soong PL, Tiburcy M, Zimmermann WH. Cardiac differentiation of human embryonic stem cells and their assembly into engineered heart muscle. Curr Protoc Cell Biol 2012; Chapter 23:Unit23.8. (doi: 10.1002/0471143030.cb2308s55) PMID: 23129117.
38. Soonpaa M.H., Kim K.K., Pajak L., Franklin M., Field L.J. Cardiomyocyte DNA synthesis and binucleation during murine development. American Journal of Physiology 1996, 271:H2183-H2189.
39. Stevens K.R., Pabon L., Muskheli V., Murry C.E. Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Engineering Part A 2009, 15:1211-1222.
40. Streckfuss-Bomeke K., Wolf F., Azizian A., et al. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. European Heart Journal 2012, Jul 12. [Epub ahead of print] PMID: 22798560.
41. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
42. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
43. Tandon N., Cannizzaro C., Chao P.H., et al. Electrical stimulation systems for cardiac tissue engineering. Nature Protocols 2009, 4:155-173.
44. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
45. Tiburcy M., Didie M., Boy O., et al. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Circulation Research 2011, 109:1105-1114.
46. Tulloch N.L., Muskheli V., Razumova M.V., et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circulation Research 2011, 109:47-59.
47. Vantler M., Karikkineth B.C., Naito H., et al. PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue. Journal of Molecular and Cellular Cardiology 2010, 48:1316-1323.
48. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. Journal of the American College of Cardiology 1989, 13:1637-1652.
49. Yildirim Y., Naito H., Didie M., et al. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 2007, 116:I16-I23.
50. Yusa K., Rashid S.T., Strick-Marchand H., et al. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011, 478:391-394.
51. Zhang D., Shadrin I.Y., Lam J., Xian H.Q., Snodgrass H.R., Bursac N. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013, 34:5813-5820.
52. Zimmermann W.H., Didie M., Wasmeier G.H., et al. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 2002, 106:I151-I157.
53. Zimmermann W.H., Fink C., Kralisch D., Remmers U., Weil J., Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnology and Bioengineering 2000, 68:106-114.
54. Zimmermann W.H., Melnychenko I., Wasmeier G., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Medicine 2006, 12:452-458.
55. Zimmermann W.H., Schneiderbanger K., Schubert P., et al. Tissue engineering of a differentiated cardiac muscle construct. Circulation Research 2002, 90:223-230.